Brandi Roberts
CIK 1516354 · Chief Financial Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.31M
Companies
7
Total Filings
32
Lifetime Open-Market Net
-$106.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DFTX | Chief Financial Officer | 209,487 | $44.39 | $9.30M | -$135.7K | 3 | 2026-06-26 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Chief Financial Officer | — | $15.00 | — | $0 | 1 | 2025-06-02 |
| Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Executive VP and CFO | 15,090 | $59.98 | $905.1K | $0 | 5 | 2024-12-02 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 23,165 | $0.07 | $1.5K | $5.0K | 5 | 2024-07-08 |
| LCTX | CFO & SVP Finance | 5,000 | $1.14 | $5.7K | $5.0K | 2 | 2020-03-19 |
| MSTX | Chief Financial Officer & SVP | 54 | $8.86 | $478 | $19.0K | 7 | 2017-01-23 |
| Savara Inc (ANX) Delisted | Chief Financial Officer & SVP | — | — | — | $0 | 3 | 2013-01-03 |
Recent Filings · Page 2 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-04 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-15 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +20,000 | $5.0K | EDGAR |
| 2023-02-10 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-30 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-11 | Longboard Pharmaceuticals, Inc. (LBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-19 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2019-08-15 | LCTX | Buy (P) | +5,000 | $5.0K | EDGAR |
| 2019-07-02 | — | Grant (A) | — | $0 | |
| 2019-01-09 | — | Grant (A) | — | $0 | |
| 2018-07-02 | — | Buy (P) | +4,907 | $7.5K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.